I think you put too much focus on a single sentence, SPA delay, and are ignoring the rest of the great things he laid out. The president specifically described how B was not delayed, but currently has two other indications actively in clinical trials that will add value to the platform. Not to mention his comments on P and K - I am excited for the near term future of this stock.